home > drugs a-z list > optison (perflutren protein-type a microspheres) drug center > optison (perflutren protein-type a microspheres) drug - medication guide and patient information

Optison

font size

PATIENT INFORMATION

Patients receiving OPTISON (perflutren protein-type a microspheres) should be instructed to inform their healthcare provider if they:

  1. have a congenital heart defect, or recent worsening of heart or lung conditions;
  2. have had reactions to blood, blood products, albumin or a prior OPTISON administration (see CONTRAINDICATIONS and WARNINGS);
  3. may be pregnant or are nursing an infant.

Last reviewed on RxList: 7/9/2008
This monograph has been modified to include the generic and brand name in many instances.

Additional Optison Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

Heart Health

Get the latest treatment options.


From WebMD

Healthy Heart Resources
Featured Centers
Health Solutions From Our Sponsors